Alcon AG (ALC)
Alcon AG is a healthcare company focused on eye care products worldwide. Listed on the NYSE as common stock under the ticker ALC, the company operates through two main segments, Surgical and Vision Care. Its Surgical business includes equipment, diagnostics, intraocular lenses, implantables, and a range of consumables used in ophthalmic procedures. The Vision Care segment covers contact lenses and eye health products. Alcon’s portfolio spans cataract surgery systems and digital tools, refractive surgery products used in LASIK procedures, vitreoretinal instruments, and contact lenses, along with products for dry eye, glaucoma, ocular allergies, and lens care. The company was founded in 1945 and is headquartered in Geneva, Switzerland. It was previously known as Alcon Universal S.A. before adopting the Alcon Inc. name in 2001.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-ALC
|
$82.04
|
19.7% Upside
|
Undervalued
|
$87.32
|
27.4% Upside
|
Undervalued
|
Great
|
—
|
—
|
0.182
|
0.3%
|
August 10, 2026
|
41.0x
|
1.5x
|
3.2x
|
34.171 B
|
36.521 B
|
13.3%
|
99.7%
|
8.1
|
20.3%
|
211.1%
|
